• 36
  • 5
  • Favorite

India says J&J withdraws proposal for speedy vaccine approval

Reuters2021-08-02

(Adds details, background)

BENGALURU, Aug 2 (Reuters) - India's drug regulator said on Monday that Johnson & Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details.

The U.S.-based company had said in April it was seeking an approval to conduct a bridging clinical study of its Janssen COVID-19 vaccine candidate in India. Trials in the United States at that time were paused on reports of rare blood clots.

The drugmaker's withdrawal comes as India tackles legal challenges with manufacturers over indemnity issues, with its junior health minister saying last week that a team had been formed to engage with vaccine makers.

"This team is in continuous dialogue with Pfizer, Moderna and Johnson & Johnson to discuss and address various issues including the issue of indemnity," Bharati Pravin Pawar had said.

Johnson & Johnson and the Central Drugs Standard Control Organisation (CDSCO) did not immediately respond to Reuters' requests for comments on why the company withdrew its application.

As of July 31, Johnson & Johnson is yet to request a full approval for its shot with the U.S. FDA, while Pfizer Inc, BioNTech SE , and Moderna Inc have already sought full approval of their vaccines with the FDA.

In India, the drug regulator had given emergency use authorisation to Moderna's vaccine in June.

(Reporting by Shivani Singh in Bengaluru; editing by Uttaresh.V)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment5

  • snb
    ·2021-08-02
    Sad
    Reply
    Report
  • FCY
    ·2021-08-02
    Why still negotiating with the vaccine makers when the covid is still rampant in india?
    Reply
    Report
  • Soojj
    ·2021-08-02
    Wow
    Reply
    Report
    Fold Replies
    • Soojj
      Ok
      2021-08-02
      Reply
      Report
  • tyng8825
    ·2021-08-02
    Good
    Reply
    Report
    Fold Replies
    • domobc
      like pleaze
      2021-08-02
      Reply
      Report
  • tyng8825
    ·2021-08-02
    Good 
    Reply
    Report
    Fold Replies
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial